Cutler Group LP Intra Cellular Therapies, Inc. Put Options Transaction History

Cutler Group LP

16 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2023 Jan 18, 2024	BUY	$46.37 - $73.65 $9,274 - $14,730	200 New	200 $0
Q4 2021 Jan 18, 2022	BUY	$35.2 - $53.42 $88,000 - $133,550	2,500 Added 192.31%	3,800 $1,000
Q1 2021 Apr 26, 2021	SELL	$30.8 - $39.51 $89,320 - $114,579	-2,900 Reduced 69.05%	1,300 $4,000
Q4 2020 Jan 21, 2021	SELL	$23.34 - $32.22 $102,696 - $141,768	-4,400 Reduced 51.16%	4,200 $11,000
Q3 2020 Oct 27, 2020	BUY	$17.61 - $31.86 $66,918 - $121,068	3,800 Added 79.17%	8,600 $44,000
Q2 2020 Jul 22, 2020	BUY	$14.35 - $26.64 $20,090 - $37,296	1,400 Added 41.18%	4,800 $36,000
Q1 2020 May 07, 2020	SELL	$12.31 - $33.12 $765,682 - $2.06 Million	-62,200 Reduced 94.82%	3,400 $35,000
Q4 2019 Feb 06, 2020	BUY	$7.26 - $38.49 $37,752 - $200,148	5,200 Added 8.61%	65,600 $25,000
Q3 2019 Oct 28, 2019	BUY	$7.47 - $14.03 $443,718 - $833,382	59,400 Added 5940.0%	60,400 $73,000
Q2 2019 Aug 09, 2019	SELL	$10.65 - $14.29 $435,585 - $584,461	-40,900 Reduced 97.61%	1,000 $2,000
Q4 2018 Feb 05, 2019	BUY	$10.36 - $20.96 $91,168 - $184,448	8,800 Added 26.59%	41,900 $21,000
Q3 2018 Nov 07, 2018	SELL	$17.77 - $22.9 $51,533 - $66,410	-2,900 Reduced 8.06%	33,100 $12,000
Q2 2018 Aug 10, 2018	BUY	$17.33 - $23.4 $38,125 - $51,480	2,200 Added 6.51%	36,000 $44,000
Q1 2018 May 11, 2018	BUY	$15.16 - $25.49 $33,352 - $56,078	2,200 Added 6.96%	33,800 $39,000
Q4 2017 Jan 17, 2018	SELL	$14.27 - $16.79 $590,778 - $695,106	-41,400 Reduced 56.71%	31,600 $22,000
Q3 2017 Oct 17, 2017	BUY	$10.77 - $22.1 $786,210 - $1.61 Million	73,000	73,000 $127,000

378

84.1M

319K

143K

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $7.86B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.